MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
ENSC Ensysce Biosciences
- 9.9800
- +1.7200+20.82%
Close Dec 24 13:00 ET
- 10.0000
- +0.0200+0.20%
Pre 04:41 ET
13.02MMarket Cap-0.34P/E (TTM)
10.9600High8.0200Low230.87KVolume8.4900Open8.2600Pre Close2.26MTurnover23.92%Turnover RatioLossP/E (Static)1.30MShares30.900052wk High1.88P/B9.63MFloat Cap2.118052wk Low--Dividend TTM965.13KShs Float86364.0000Historical High--Div YieldTTM35.59%Amplitude2.1150Historical Low9.7820Avg Price1Lot Size
Ensysce Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 54.91%-1.02M | 25.69%-2.31M | 5.50%-3.41M | 39.73%-10.78M | 45.33%-1.8M | 66.30%-2.26M | 30.00%-3.11M | -4.94%-3.61M | -117.02%-17.89M | 12.53%-3.3M |
| Net income from continuing operations | 124.59%661.77K | 12.12%-1.97M | -42.19%-3.12M | 56.10%-10.63M | 36.03%-3.5M | 72.70%-2.69M | 71.74%-2.24M | -130.49%-2.19M | 16.94%-24.21M | 45.42%-5.48M |
| Operating gains losses | 62.83%-6.4K | 82.08%-7.82K | 95.91%-8.96K | 95.78%-283.96K | 99.92%-4.09K | -101.63%-17.22K | 70.60%-43.62K | 92.17%-219.03K | -145.65%-6.74M | -240.02%-4.84M |
| Other non cash items | -46.58%4.06K | 62,747.73%27.57K | 926.56%1.2M | -95.84%344.65K | -91.76%482.12K | -99.70%7.6K | -100.00%-44 | 86.18%-145.03K | 13.13%8.29M | 27.84%5.85M |
| Change In working capital | -545.05%-1.7M | 56.99%-388.39K | -29.67%-1.51M | -117.28%-947.08K | -73.01%742K | 167.25%382.11K | -138.58%-902.99K | -221.69%-1.17M | 520.55%5.48M | 254.36%2.75M |
| -Change in receivables | -974,013.75%-1.56M | -170.43%-128K | 110.70%1.34K | 8.71%179.26K | 107.48%10.18K | -100.12%-160 | -65.84%181.73K | 96.60%-12.49K | 137.33%164.9K | 61.67%-136.01K |
| -Change in prepaid assets | -350.72%-1.92M | 22.40%277.61K | -135.74%-86.7K | -15.77%1.39M | -86.67%156.93K | 20.80%765.85K | 130.64%226.81K | -58.31%242.59K | 202.27%1.65M | 226.24%1.18M |
| -Change in payables and accrued expense | 563.57%1.78M | 58.98%-538K | -2.23%-1.43M | -168.73%-2.52M | -66.35%574.89K | 71.33%-383.58K | -151.46%-1.31M | -287.70%-1.4M | 385.80%3.66M | 445.84%1.71M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 54.91%-1.02M | 25.69%-2.31M | 5.50%-3.41M | 39.73%-10.78M | 45.33%-1.8M | 66.30%-2.26M | 30.00%-3.11M | -4.94%-3.61M | -117.02%-17.89M | 12.53%-3.3M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 4.5K | 0 | |||||||
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.5K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --4.5K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4,131.70%4.13M | -100.93%-51.23K | 203.42%5.69M | -0.11%8.76M | -24.70%1.46M | -101.37%-102.46K | 2,177.51%5.52M | 579.20%1.87M | -56.85%8.77M | -78.88%1.94M |
| Net issuance payments of debt | --0 | --0 | -16.81%-485.19K | -90.12%605.43K | 240.53%1.61M | --0 | -120.03%-584.86K | ---415.35K | -55.97%6.13M | -112.05%-1.14M |
| Net common stock issuance | --1.67M | --0 | --0 | 139.21%9.05M | --0 | --0 | --6.36M | --2.69M | -42.91%3.78M | --3.78M |
| Proceeds from stock option exercised by employees | --3.85M | --0 | --6.33M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | -1,257.15%-1.39M | 79.82%-51.23K | 61.46%-153.68K | 21.29%-899.55K | 79.37%-144.54K | -100.23%-102.46K | ---253.84K | -1.90%-398.72K | -133.94%-1.14M | -138.96%-700.45K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4,131.70%4.13M | -100.93%-51.23K | 203.42%5.69M | -0.11%8.76M | -24.70%1.46M | -101.37%-102.46K | 2,177.51%5.52M | 579.20%1.87M | -56.85%8.77M | -78.88%1.94M |
| Net cash flow | ||||||||||
| Beginning cash position | -72.76%1.04M | 140.46%3.4M | -64.30%1.12M | -74.34%3.15M | -67.48%1.46M | 2.54%3.83M | -83.23%1.42M | -74.34%3.15M | 6,215.06%12.26M | -34.22%4.5M |
| Current changes in cash | 231.51%3.11M | -197.82%-2.36M | 231.69%2.28M | 77.80%-2.02M | 74.86%-340.78K | -407.78%-2.37M | 151.29%2.41M | 54.71%-1.73M | -175.53%-9.12M | -125.01%-1.36M |
| End cash Position | 183.64%4.15M | -72.76%1.04M | 140.46%3.4M | -64.30%1.12M | -64.30%1.12M | -67.48%1.46M | 2.54%3.83M | -83.23%1.42M | -74.34%3.15M | -74.34%3.15M |
| Free cash flow | 54.91%-1.02M | 25.69%-2.31M | 5.50%-3.41M | 39.73%-10.78M | 45.33%-1.8M | 66.30%-2.26M | 30.00%-3.11M | -4.94%-3.61M | -117.02%-17.89M | 12.53%-3.3M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
